Anti-tumor activity of dual inhibition of phosphatidylinositol 3-kinase and MDM2 against clear cell ovarian carcinoma

2019 ◽  
Vol 155 (2) ◽  
pp. 331-339
Author(s):  
Chinami Makii ◽  
Yuji Ikeda ◽  
Katsutoshi Oda ◽  
Yuriko Uehara ◽  
Akira Nishijima ◽  
...  
Keyword(s):  
Ovarian Carcinoma ◽  
Clear Cell ◽  
Phosphatidylinositol 3 Kinase ◽  
Clear Cell Ovarian Carcinoma ◽  
Dual Inhibition ◽  
Anti Tumor Activity ◽  
Phosphatidylinositol 3

Comparison of surgical and oncologic outcomes in patients with clear cell ovarian carcinoma associated with and without endometriosis

2021 ◽  
Author(s):  
Ruja Charatsingha ◽  
Suchanan Hanamornroongruang ◽  
Mongkol Benjapibal ◽  
Suwanit Therasakvichya ◽  
Atthapon Jaishuen ◽  
...  
Keyword(s):  
Ovarian Carcinoma ◽  
Clear Cell ◽  
Oncologic Outcomes ◽  
Clear Cell Ovarian Carcinoma

The role of FOXC1 in clear cell ovarian carcinoma: Potential prognostic biomarker for aggressive disease?

2015 ◽  
Vol 139 (1) ◽  
pp. 204
Author(s):  
T.J. Vogel ◽  
J. Cohen ◽  
B. Han ◽  
A.E. Walts ◽  
X. Zhang ◽  
...  
Keyword(s):  
Ovarian Carcinoma ◽  
Clear Cell ◽  
Prognostic Biomarker ◽  
Aggressive Disease ◽  
Clear Cell Ovarian Carcinoma

scholarly journals L1CAM expression associates with poor outcome in endometrioid, but not in clear cell ovarian carcinoma

2017 ◽  
Vol 146 (3) ◽  
pp. 615-622 ◽  
Author(s):  
Piret Soovares ◽  
Annukka Pasanen ◽  
Ralf Bützow ◽  
Heini Lassus
Keyword(s):  
Ovarian Carcinoma ◽  
Clear Cell ◽  
Poor Outcome ◽  
Clear Cell Ovarian Carcinoma ◽  
L1cam Expression

Abstract GMM-052: EVIDENCE FOR APOBEC MUTAGENESIS IN CLEAR CELL OVARIAN CARCINOMA

2019 ◽  
Author(s):  
Artur S. Serebrenik ◽  
Matthew C. Jarvis ◽  
Prokopios P. Argyris ◽  
William B. Brown ◽  
Reuben S. Harris
Keyword(s):  
Ovarian Carcinoma ◽  
Clear Cell ◽  
Clear Cell Ovarian Carcinoma
Sign in / Sign up

Export Citation Format

Share Document